M0100 — Intragastric hypothermia using gastric freezing
M0201 — Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s) are performed at the patient's home
M0224 — Intravenous infusion, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, includes infusion and post administration monitoring
M0235 — Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, not otherwise classified, first dose
M0236 — Intravenous infusion, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, not otherwise classified, second dose
M0237 — Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, first dose
M0238 — Intravenous infusion, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, second dose
M0249 — Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, first dose
M0250 — Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO) only, includes infusion and post administration monitoring, second dose
M0300 — Iv chelation therapy (chemical endarterectomy)
M1003 — Tb screening performed and results interpreted within twelve months prior to initiation of first-time biologic and/or immune response modifier therapy
M1004 — Documentation of medical reason for not screening for tb or interpreting results (i.e., patient positive for tb and documentation of past treatment; patient who has recently completed a course of anti-tb therapy)
M1005 — Tb screening not performed or results not interpreted, reason not given
M1006 — Disease activity not assessed, reason not given
M1007 — >=50% of total number of a patient's outpatient ra encounters assessed
M1008 — <50% of total number of a patient's outpatient ra encounters assessed
M1009 — Discharge/discontinuation of the episode of care documented in the medical record
M1010 — Discharge/discontinuation of the episode of care documented in the medical record
M1011 — Discharge/discontinuation of the episode of care documented in the medical record
M1012 — Discharge/discontinuation of the episode of care documented in the medical record
M1013 — Discharge/discontinuation of the episode of care documented in the medical record
M1014 — Discharge/discontinuation of the episode of care documented in the medical record
M1018 — Patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients
M1019 — Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5
M1020 — Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5
M1021 — Patient had only urgent care visits during the performance period
M1027 — Imaging of the head (ct or mri) was obtained
M1028 — Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained
M1029 — Imaging of the head (ct or mri) was not obtained, reason not given
M1032 — Adults currently taking pharmacotherapy for oud
M1034 — Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
M1035 — Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment
M1036 — Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days
M1037 — Patients with a diagnosis of lumbar spine region cancer at the time of the procedure
M1038 — Patients with a diagnosis of lumbar spine region fracture at the time of the procedure
M1039 — Patients with a diagnosis of lumbar spine region infection at the time of the procedure
M1040 — Patients with a diagnosis of lumbar idiopathic or congenital scoliosis
M1041 — Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis
M1043 — Functional status was not measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively
M1045 — Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was greater than or equal to 37 or knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was greater than or equal to 71
M1046 — Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was less than 37 or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was less than 71 postoperatively
M1049 — Functional status was not measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively
M1051 — Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis
M1052 — Leg pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively
M1054 — Patient had only urgent care visits during the performance period
M1055 — Aspirin or another antiplatelet therapy used
M1056 — Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease
M1057 — Aspirin or another antiplatelet therapy not used, reason not given
M1058 — Patient was a permanent nursing home resident at any time during the performance period
M1059 — Patient was in hospice or receiving palliative care at any time during the performance period
M1060 — Patient died prior to the end of the performance period
M1067 — Hospice services for patient provided any time during the measurement period
M1070 — Patient not screened for future fall risk, reason not given
M1106 — The start of an episode of care documented in the medical record
M1107 — Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1108 — Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1109 — Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1110 — Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1111 — The start of an episode of care documented in the medical record
M1112 — Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1113 — Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1114 — Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1115 — Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1116 — The start of an episode of care documented in the medical record
M1117 — Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1118 — Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1119 — Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1120 — Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1121 — The start of an episode of care documented in the medical record
M1122 — Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1123 — Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1124 — Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1125 — Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1126 — The start of an episode of care documented in the medical record
M1127 — Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1128 — Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1129 — Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1130 — Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1131 — Documentation stating patient has a diagnosis of a degenerative neurological condition such as als, ms, or parkinson's diagnosed at any time before or during the episode of care
M1132 — Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1133 — Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1134 — Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1135 — The start of an episode of care documented in the medical record
M1141 — Functional status was not measured by the oxford knee score (oks) or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) at one year (9 to 15 months) postoperatively
M1143 — Initiated episode of rehabilitation therapy, medical, or chiropractic care for neck impairment
M1146 — Ongoing care not clinically indicated because the patient needed a home program only, referral to another provider or facility, or consultation only, as documented in the medical record
M1147 — Ongoing care not medically possible because the patient was discharged early due to specific medical events, documented in the medical record, such as the patient became hospitalized or scheduled for surgery
M1148 — Ongoing care not possible because the patient self-discharged early (e.g., financial or insurance reasons, transportation problems, or reason unknown)
M1149 — Patient unable to complete the neck fs prom at initial evaluation and/or discharge due to blindness, illiteracy, severe mental incapacity or language incompatibility, and an adequate proxy is not available
M1150 — Current or prior left ventricular ejection fraction (lvef) less than or equal to 40% or documentation of moderately or severely depressed left ventricular systolic function
M1151 — Patients with a history of heart transplant or with a left ventricular assist device (lvad)
M1152 — Patients with a history of heart transplant or with a left ventricular assist device (lvad)
M1153 — Patient with diagnosis of osteoporosis on date of encounter
M1159 — Hospice services provided to patient any time during the measurement period
M1160 — Patient had anaphylaxis due to the meningococcal vaccine any time on or before the patient's 13th birthday
M1161 — Patient had anaphylaxis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday
M1162 — Patient had encephalitis due to the tetanus, diphtheria or pertussis vaccine any time on or before the patient's 13th birthday
M1163 — Patient had anaphylaxis due to the hpv vaccine any time on or before the patient's 13th birthday
M1164 — Patients with dementia any time during the patient's history through the end of the measurement period
M1165 — Patients who use hospice services any time during the measurement period
M1166 — Pathology report for tissue specimens produced from wide local excisions or re-excisions
M1167 — In hospice or using hospice services during the measurement period
M1168 — Patient received an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
M1169 — Documentation of medical reason(s) for not administering influenza vaccine (e.g., prior anaphylaxis due to the influenza vaccine)
M1170 — Patient did not receive an influenza vaccine on or between july 1 of the year prior to the measurement period and june 30 of the measurement period
M1171 — Patient received at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period
M1172 — Documentation of medical reason(s) for not administering td or tdap vaccine (e.g., prior anaphylaxis due to the td or tdap vaccine or history of encephalopathy within seven days after a previous dose of a td-containing vaccine)
M1173 — Patient did not receive at least one td vaccine or one tdap vaccine between nine years prior to the encounter and the end of the measurement period
M1174 — Patient received at least two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period
M1175 — Documentation of medical reason(s) for not administering zoster vaccine (e.g., prior anaphylaxis due to the zoster vaccine)
M1176 — Patient did not receive two doses of the herpes zoster recombinant vaccine (at least 28 days apart) anytime on or after the patient's 50th birthday before or during the measurement period
M1177 — Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
M1178 — Documentation of medical reason(s) for not administering pneumococcal vaccine (e.g., prior anaphylaxis due to the pneumococcal vaccine)
M1179 — Patient did not receive any pneumococcal conjugate or polysaccharide vaccine, on or after their 19th birthday and before or during measurement period
M1180 — Patients on immune checkpoint inhibitor therapy
M1181 — Grade 2 or above diarrhea and/or grade 2 or above colitis
M1182 — Patients not eligible due to pre-existing inflammatory bowel disease (ibd) (e.g., ulcerative colitis, crohn's disease)
M1183 — Documentation of immune checkpoint inhibitor therapy held and corticosteroids or immunosuppressants prescribed or administered
M1184 — Documentation of medical reason(s) for not prescribing or administering corticosteroid or immunosuppressant treatment (e.g., allergy, intolerance, infectious etiology, pancreatic insufficiency, hyperthyroidism, prior bowel surgical interventions, celiac disease, receiving other medication, awaiting diagnostic workup results for alternative etiologies, other medical reasons/contraindication)
M1185 — Documentation of immune checkpoint inhibitor therapy not held and/or corticosteroids or immunosuppressants prescribed or administered was not performed, reason not given
M1186 — Patients who have an order for or are receiving hospice or palliative care
M1187 — Patients with a diagnosis of end stage renal disease (esrd)
M1188 — Patients with a diagnosis of chronic kidney disease (ckd) stage 5
M1189 — Documentation of a kidney health evaluation defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr) performed
M1190 — Documentation of a kidney health evaluation was not performed or defined by an estimated glomerular filtration rate (egfr) and urine albumin-creatinine ratio (uacr)
M1191 — Hospice services provided to patient any time during the measurement period
M1192 — Patients with an existing diagnosis of squamous cell carcinoma of the esophagus
M1193 — Surgical pathology reports that contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both
M1194 — Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)
M1195 — Surgical pathology reports that do not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both, reason not given
M1196 — Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4
M1197 — Itch severity assessment score is reduced by 3 or more points from the initial (index) assessment score to the follow-up visit score
M1198 — Itch severity assessment score was not reduced by at least 3 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter
M1200 — Ace inhibitor (ace-i) or arb therapy prescribed during the measurement period
M1201 — Documentation of medical reason(s) for not prescribing ace inhibitor (ace-i) or arb therapy during the measurement period (e.g., pregnancy, history of angioedema to ace-i, other allergy to ace-i and arb, hyperkalemia or history of hyperkalemia while on ace-i or arb therapy, acute kidney injury due to ace-i or arb therapy), other medical reasons)
M1202 — Documentation of patient reason(s) for not prescribing ace inhibitor or arb therapy during the measurement period, (e.g., patient declined, other patient reasons)
M1203 — Ace inhibitor or arb therapy not prescribed during the measurement period, reason not given
M1204 — Initial (index visit) numeric rating scale (nrs), visual rating scale (vrs), or itchyquant assessment score of greater than or equal to 4
M1205 — Itch severity assessment score is reduced by 3 or more points from the initial (index) assessment score to the follow-up visit score
M1206 — Itch severity assessment score was not reduced by at least 3 points from initial (index) score to the follow-up visit score or assessment was not completed during the follow-up encounter
M1207 — Patient is screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety
M1208 — Patient is not screened for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety
M1209 — At least two orders for high-risk medications from the same drug class, (table 4), without appropriate diagnoses
M1210 — At least two orders for high-risk medications from the same drug class, (table 4), not ordered
M1211 — Most recent glycemic status assessment (hba1c or gmi) level > 9.0%
M1212 — Glycemic status assessment (hba1c or gmi) level is missing, or was not performed during the measurement period
M1213 — No history of spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) and present spirometry is >= 70%
M1214 — Spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and reviewed
M1215 — Documentation of medical reason(s) for not documenting and reviewing spirometry results (e.g., patients with dementia or tracheostomy)
M1216 — No spirometry results with confirmed airflow obstruction (fev1/fvc < 70%) documented and/or no spirometry performed with results documented during the encounter
M1217 — Documentation of system reason(s) for not documenting and reviewing spirometry results (e.g., spirometry equipment not available at the time of the encounter)
M1218 — Patient has copd symptoms (e.g., dyspnea, cough/sputum, wheezing)
M1220 — Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; with evidence of retinopathy
M1221 — Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist or artificial intelligence (ai) interpretation documented and reviewed; without evidence of retinopathy
M1222 — Glaucoma plan of care not documented, reason not otherwise specified
M1228 — Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test
M1229 — Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection
M1230 — Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not given
M1231 — Patient receives hcv antibody test with nonreactive result
M1232 — Patient receives hcv antibody test with reactive result
M1233 — Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given
M1234 — Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremia
M1235 — Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance period
M1237 — Patient reason for not screening for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety (e.g., patient declined or other patient reasons)
M1238 — Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)
M1239 — Patient did not respond to the question of patient felt heard and understood by this provider and team
M1240 — Patient did not respond to the question of patient felt this provider and team put my best interests first when making recommendations about my care
M1241 — Patient did not respond to the question of patient felt this provider and team saw me as a person, not just someone with a medical problem
M1242 — Patient did not respond to the question of patient felt this provider and team understood what is important to me in my life
M1243 — Patient provided a response other than "completely true" for the question of patient felt heard and understood by this provider and team
M1244 — Patient provided a response other than "completely true" for the question of patient felt this provider and team put my best interests first when making recommendations about my care
M1245 — Patient provided a response other than "completely true" for the question of patient felt this provider and team saw me as a person, not just someone with a medical problem
M1246 — Patient provided a response other than "completely true" for the question of patient felt this provider and team understood what is important to me in my life
M1247 — Patient responded "completely true" for the question of patient felt this provider and team put my best interests first when making recommendations about my care
M1248 — Patient responded "completely true" for the question of patient felt this provider and team saw me as a person, not just someone with a medical problem
M1249 — Patient responded "completely true" for the question of patient felt this provider and team understood what is important to me in my life
M1250 — Patient responded as "completely true" for the question of patient felt heard and understood by this provider and team
M1251 — Patients for whom a proxy completed the entire hu survey on their behalf for any reason (no patient involvement)
M1252 — Patients who did not complete at least one of the four patient experience hu survey items and return the hu survey within 60 days of the ambulatory palliative care visit
M1253 — Patients who respond on the patient experience hu survey that they did not receive care by the listed ambulatory palliative care provider in the last 60 days (disavowal)
M1254 — Patients who were deceased when the hu survey reached them
M1255 — Patients who have another reason for visiting the clinic [not prenatal or postpartum care] and have a positive pregnancy test but have not established the clinic as an ob provider (e.g., plan to terminate the pregnancy or seek prenatal services elsewhere)
M1257 — Cvd risk assessment not performed or incomplete (e.g., cvd risk assessment was not documented), reason not otherwise specified
M1258 — Cvd risk assessment performed, have a documented calculated risk score
M1259 — Patient status documented within the first year of initiating dialysis
M1260 — Patient status not documented within the first year of initiating dialysis
M1261 — Patients that were on the kidney or kidney-pancreas waitlist prior to initiation of dialysis
M1262 — Patients who had a transplant prior to initiation of dialysis
M1263 — Patients in hospice on their initiation of dialysis date or during the month of evaluation
M1265 — Cms medical evidence form 2728 for dialysis patients: initial form completed
M1266 — Patients admitted to a skilled nursing facility (snf)
M1267 — Patients not observed in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period
M1268 — Patients observed in active status on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period
M1269 — Receiving esrd mcp dialysis services by the provider on the last day of the reporting month
M1270 — Patients not on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period
M1271 — Patients with dementia at any time prior to or during the month
M1272 — Patients observed on any kidney or kidney-pancreas transplant waitlist as of the last day of each month during the measurement period
M1273 — Patients who were admitted to a skilled nursing facility (snf) within one year of dialysis initiation according to the cms-2728 form
M1274 — Patients who were admitted to a skilled nursing facility (snf) during the month of evaluation were excluded from that month
M1275 — Patients determined to be in hospice were excluded from month of evaluation and the remainder of reporting period
M1276 — Bmi documented outside normal parameters, no follow-up plan documented, no reason given
M1277 — Colorectal cancer screening results documented and reviewed
M1278 — Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented
M1279 — Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given
M1280 — Women who had a bilateral mastectomy or who have a history of a bilateral mastectomy or for whom there is evidence of a right and a left unilateral mastectomy
M1281 — Blood pressure reading not documented, reason not given
M1282 — Patient screened for tobacco use and identified as a tobacco non-user
M1283 — Patient screened for tobacco use and identified as a tobacco user
M1284 — Patients age 66 or older in institutional special needs plans (snp) or residing in long term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period
M1285 — Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results were not documented and reviewed, reason not otherwise specified
M1286 — Bmi is documented as being outside of normal parameters, follow-up plan is not completed for documented medical reason
M1287 — Bmi is documented below normal parameters and a follow-up plan is documented
M1288 — Documented reason for not screening or recommending a follow-up for high blood pressure
M1289 — Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
M1290 — Patient not eligible due to active diagnosis of hypertension
M1291 — Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and a dispensed medication for dementia during the measurement period or the year prior to the measurement period
M1292 — Patients 66 years of age and older with at least one claim/encounter for frailty during the measurement period and an advanced illness diagnosis during the measurement period or the year prior to the measurement period
M1293 — Bmi is documented above normal parameters and a follow-up plan is documented
M1294 — Normal blood pressure reading documented, follow-up not required
M1295 — Patients with a diagnosis or past history of total colectomy or colorectal cancer
M1296 — Bmi is documented within normal parameters and no follow-up plan is required
M1297 — Bmi not documented due to medical reason or patient refusal of height or weight measurement
M1298 — Documentation of patient pregnancy anytime during the measurement period prior to and including the current encounter
M1299 — Influenza immunization administered or previously received
M1300 — Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)
M1301 — Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy)
M1302 — Screening, diagnostic, film digital or digital breast tomosynthesis (3d) mammography results documented and reviewed
M1303 — Hospice services provided to patient any time during the measurement period
M1304 — Patient did not receive any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
M1305 — Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period
M1306 — Patient had anaphylaxis due to the pneumococcal vaccine any time during or before the measurement period
M1307 — Documentation stating the patient has received or is currently receiving palliative or hospice care
M1308 — Influenza immunization was not administered, reason not given
M1309 — Palliative care services provided to patient any time during the measurement period
M1310 — Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user
M1311 — Anaphylaxis due to the vaccine on or before the date of the encounter
M1313 — Tobacco screening not performed or tobacco cessation intervention not provided during the measurement period or in the six months prior to the measurement period
M1317 — Patients who are counseled on connection with a csp and explicitly opt out
M1318 — Patients who did not have documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening or documentation that there was no contact with a csp
M1319 — Patients who had documented contact with a csp for at least one of their screened positive hrsns within 60 days after screening
M1320 — Patients who screened positive for at least 1 of the 5 hrsns
M1321 — Patients who were not seen within 7 weeks following the date of injection for follow up or who did not have a documented iop or no plan of care documented if the iop was >25 mm hg
M1322 — Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop =<25 mm hg for injected eye
M1323 — Patients seen within 7 weeks following the date of injection and are screened for elevated intraocular pressure (iop) with tonometry with documented iop >25 mm hg and a plan of care was documented
M1324 — Patients who had an intravitreal or periocular corticosteroid injection (e.g., triamcinolone, preservative-free triamcinolone, dexamethasone, dexamethasone intravitreal implant, or fluocinolone intravitreal implant)
M1325 — Patients who were not seen for reasons documented by clinician for patient or medical reasons (e.g., inadequate time for follow-up, patients who received a prior intravitreal or periocular steroid injection within the last six (6) months and had a subsequent iop evaluation with iop <25mm hg within seven (7) weeks of treatment)
M1327 — Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 8 weeks
M1328 — Patients with a diagnosis of acute vitreous hemorrhage
M1329 — Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 8 weeks after initial acute pvd encounter
M1330 — Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
M1331 — Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 8 weeks from initial exam
M1332 — Patients who were not appropriately evaluated during the initial exam and/or who were not re-evaluated within 2 weeks
M1334 — Patients with a post-operative encounter of the eye with the acute pvd within 2 weeks before the initial encounter or 2 weeks after initial acute pvd encounter
M1335 — Documentation of patient reason(s) for not having a follow up exam (e.g., inadequate time for follow up)
M1336 — Patients who were appropriately evaluated during the initial exam and were re-evaluated no later than 2 weeks
M1338 — Patients who had follow-up assessment 30 to 180 days after the index assessment who did not demonstrate positive improvement or maintenance of functioning scores during the performance period
M1339 — Patients who had follow-up assessment 30 to 180 days after the index assessment who demonstrated positive improvement or maintenance of functioning scores during the performance period
M1340 — Index assessment completed using the 12-item whodas 2.0 or sds during the denominator identification period
M1341 — Patients who did not have a follow-up assessment or did not have an assessment within 30 to 180 days after the index assessment during the performance period
M1342 — Patients who died during the performance period
M1343 — Patients who are at pam level 4 at baseline or patients who are flagged with extreme straight line response sets on the pam or with excessive missing responses
M1344 — Patients who did not have a baseline pam score and/or a second score within 4 to 12 months of baseline pam score
M1345 — Patients who had a baseline pam score and a second score within 4 to 12 month of baseline pam score
M1346 — Patients who did not have a net increase in pam score of at least 6 points within a 4 to 12 month period
M1347 — Patients who achieved a net increase in pam score of at least 3 points in a 4 to 12 month period (passing)
M1348 — Patients who achieved a net increase in pam score of at least 6-points in a 4 to 12 month period (excellent)
M1349 — Patients who did not have a net increase in pam score of at least 3 points within a 4 to 12 month period
M1350 — Patients who had a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter
M1351 — Patients who had a suicide safety plan initiated, reviewed, or updated and reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation
M1352 — Suicidal ideation and/or behavior symptoms based on the c-ssrs or equivalent assessment
M1353 — Patients who did not have a completed suicide safety plan initiated, reviewed or updated in collaboration with their clinician (concurrent or within 24 hours) of the index clinical encounter
M1354 — Patients who did not have a suicide safety plan initiated, reviewed, or updated or reviewed and updated in collaboration with the patient and their clinician concurrent or within 24 hours of clinical encounter and within 120 days after initiation
M1355 — Suicide risk based on their clinician's evaluation or a clinician-rated tool
M1356 — Patients who died during the measurement period
M1357 — Patients who had a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment
M1358 — Patients who did not have a reduction in suicidal ideation and/or behavior upon follow-up assessment within 120 days of index assessment
M1359 — Index assessment during the denominator period when the suicidal ideation and/or behavior symptoms or increased suicide risk by clinician determination occurs and a non-zero c-ssrs score is obtained
M1360 — Suicidal ideation and/or behavior symptoms based on the c-ssrs
M1361 — Suicide risk based on their clinician's evaluation or a clinician-rated tool
M1362 — Patients who died during the measurement period
M1363 — Patients who did not have a follow-up assessment within 120 days of the index assessment
M1364 — Calculated 10-year ascvd risk score of >= 20 percent during the performance period
M1365 — Patient encounter during the performance period with hospice and palliative care specialty code 17
M1366 — Focusing on women's health mips value pathway
M1367 — Quality care for the treatment of ear, nose, and throat disorders mips value pathway
M1368 — Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway
M1369 — Quality care in mental health and substance use disorders mips value pathway
M1370 — Rehabilitative support for musculoskeletal care mips value pathway
M1371 — Most recent glycemic status assessment (hba1c or gmi) level < 7.0%
M1372 — Most recent glycemic status assessment (hba1c or gmi) level >= 7.0% and < 8.0%
M1373 — Most recent glycemic status assessment (hba1c or gmi) level >= 8.0% and <= 9.0%
M1374 — An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period
M1375 — An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period
M1376 — An additional encounter with an ra diagnosis during the performance period or prior performance period that is at least 90 days before or after an encounter with an ra diagnosis during the performance period
M1377 — Recommended follow-up interval for repeat colonoscopy of 10 years documented in colonoscopy report and communicated with patient
M1378 — Documentation of medical reason(s) for not recommending a 10 year follow-up interval (e.g., inadequate prep, familial or personal history of colonic polyps, patient had no adenoma and age is >= 66 years old, or life expectancy < 10 years, other medical reasons)
M1379 — A 10 year follow-up interval for colonoscopy not recommended, reason not otherwise specified
M1380 — Filled at least two prescriptions during the performance period for any combination of the qualifying oral antipsychotic medications listed under "denominator note" or the long-acting injectable antipsychotic medications listed under "denominator note"
M1381 — Patients with secondary stroke (e.g., a subsequent stroke that may occur with vasospasm in the setting of subarachnoid hemorrhage) within 5 days of the initial procedure
M1382 — Patient encounter during the performance period with place of service code 11
M1384 — Patients who died during the performance period
M1385 — Documentation of patient reasons for patients who were not seen for the second pam survey (e.g., less than four months between baseline pam assessment and follow-up
M1386 — Patients with an excisional surgery for melanoma or melanoma in situ in the past 5 years with an initial ajcc staging of 0, i, or ii at the start of the performance period
M1387 — Patients who died during the performance period
M1388 — Patients with documentation of an exam performed for recurrence of melanoma
M1390 — Patients who do not have a documented exam performed for recurrence of melanoma or no documentation within the performance period
M1391 — All patients who were diagnosed with recurrent melanoma during the current performance period
M1392 — Documentation of patient reasons for no examination, i.e., refusal of examination or lost to follow-up (documentation must include information that the clinician was unable to reach the patient by phone, mail or secure electronic mail - at least one method must be documented)
M1393 — Patients who were not diagnosed with recurrent melanoma during the current performance period
M1405 — Patients with recurrence/disease progression
M1406 — Patients who leave the practice during the follow-up period
M1407 — Patients who died during the follow-up period
M1408 — Patients who have germline brca testing completed before diagnosis of epithelial ovarian, fallopian tube, or primary peritoneal cancer
M1409 — Patients who received germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis
M1410 — Patients who did not have germline testing for brca1 and brca2 or genetic counseling completed within 6 months of diagnosis
M1411 — Currently on first-line immune checkpoint inhibitors without chemotherapy
M1412 — Patients with metastatic nsclc with epidermal growth factor receptor (egfr) mutations, alk genomic tumor aberrations, or other targetable genomic abnormalities with approved first-line targeted therapy, such as nsclc with ros1 rearrangement, braf v600e mutation, ntrk 1/2/3 gene fusion, met ex14 skipping mutation, and ret rearrangement
M1413 — Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy
M1414 — Documentation of medical reason(s) for not performing the pd-l1 biomarker expression test prior to initiation of first-line immune checkpoint inhibitor therapy (e.g., patient is in an urgent or emergent situation where delay of treatment would jeopardize the patient's health status; other medical reasons/contraindication)
M1415 — Patients who did not have a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy
M1416 — Patient received hospice services any time during the performance period
M1417 — Patients who are up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination
M1418 — Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination because of a medical contraindication documented by clinician
M1419 — Patients who are not up to date on their covid-19 vaccinations as defined by cdc recommendations on current vaccination
M1420 — Complete ophthalmologic care mips value pathway